Biological Markers in the Diagnosis of Multiple Sclerosis

Abstract

Multiple Sclerosis (MS) is a disease that affects the central nervous system. Patients with multiple sclerosis often face symptoms of numbness, fatigue, pain, and coordination problems, as well as many other issues. Through years of effort, researchers have found numerous biological markers (biomarkers) that have helped in the diagnosis of the disease. Several biomarkers have been found by examining the cerebrospinal fluid. Furthermore, the use of magnetic resonance imaging (MRI) is one of the best used tools for discovering MS biomarkers. Gene expression profiling is a new, up-and-coming method for diagnosing MS. Clinicians and researchers have discovered that patients with MS express certain genes differently, which may lead to the profound discovery of many biomarkers for the disease, with added research efforts. By spotting such biomarkers efficiently, doctors can begin the prognosis treatment sooner, ultimately saving the lives of those affected by Multiple Sclerosis.